Pharmigene, Inc. engages in the manufacturing and sales of pharmaceutical genetic diagnostic products. Its businesses include the provision of functional medical testing services; production and distribution of testing products and diagnostic tools; agency sales of laboratory equipment and consumables; and authorization of Carbamazepine, Allopurinol, and Warfarin drugs related patents for genetic testing. The company was founded by Yuan Tsong Chen on September 28, 2005 and is headquartered in Taipei, Taiwan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company